A bioavailability study comparing modified-release capsules and immediate release capsules in fed and fasting conditions

Study identifier:D1950C00008

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2009-017702-36

CTIS identifier:N/A

Study Complete

Official Title

A Phase I study to investigate the relative bioavailability of modified-release formulations of AZD1446 compared to an immediate-release capsule under fed and fasting conditions following single and repeated dose administration to young and elderly healthy volunteers

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD1446, Placebo

Sex

All

Actual Enrollment

62

Study type

Interventional

Age

18 Years - 80 Years

Date

Study Start Date: 01 Feb 2010
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010

Study design

Allocation: Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Jul 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria